A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The specific aim of this study is to evaluate the efficacy, tolerability, and safety of
zonisamide therapy in the prevention of weight gain associated with olanzapine treatment for
psychotic or bipolar disorders.